Evidence map›Paper›PMID 32612724›Full record

ArticlePolish journal of radiology2020

The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas.

Ulku Korkmaz, Muhammet Bekir Hacioglu, Osman Kostek, Necdet Sut, Hilmi Kodaz, Bulent Erdogan, Funda Ustun, Mert Saynak, Ebru Tastekin, Irfan Cicin and 1 more

Abstract read
In one paragraph

Article in Polish journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Radiology and oncology · 2026
    Article
  2. Article
  3. Volumetric Evaluation of StagingMolecular imaging and radionuclide therapy · 2022
    Article
  4. CanCancers · 2022
    Article
  5. Relationship betweenKorean journal of radiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ulku KorkmazDepartment of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.
Muhammet Bekir HaciogluDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Osman KostekDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Necdet SutDepartment of Statistics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Hilmi KodazDepartment of Medical Oncology, Acıbadem Eskişehir Hospital, Eskişehir, Turkey.
Bulent ErdoganDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Funda UstunDepartment of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.
Mert SaynakDepartment of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Ebru TastekinDepartment of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Irfan CicinDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Gulay Durmus-AltunDepartment of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose18F-fluorodeoxyglucose ( MATERIAL AND

methodsImages and clinical course data of 57 patients who were diagnosed with EC and treated in our hospital between 2009 and 2016 were evaluated in a retrospective manner. PET/CT images were re-analysed in terms of metabolic parameters, and observations were compared with histological subtypes.

resultsNo significant difference was observed between histological subtypes with SUV

conclusionsMetabolic tumour volume was related with histological subtype of OC, but clinical staging, TLG, and SUV

Indexed as

MTVoesophageal cancerPET/CTsquamous cell cancerSUVmaxTLG

Identifiers

PMID32612724
PMCPMC7315051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.